Chloe James

(She/Her)

My primary research centers around temperate bacteriophages and how their carriage alters the biology of their bacterial hosts. I also lead projects investigating virulent phages, host-pathogen interactions and antimicrobial resistance (AMR).
I am passionate about the open sharing of scientific research through public engagement and outreach. I work across disciplines and with creative practitioners to develop immersive and engaging installations to improve public interest in microbiology.

Experience

  • 2022–present
    Professor of Microbiology, University of Salford
  • 2017–2022
    Senior Lecturer in Medical Microbiology, University of Salford
  • 2012–2017
    Lecturer in Medical Microbiology, University of Salford
  • 2009–2012
    Postdoctoral Researcher, University of Liverpool
  • 2006–2008
    Postdoctoral Researcher - Marie Curie Funded, Universite Aix-Marseille
  • 2003–2006
    Postdoctoral Researcher - NIH Funded, University of Florida

Education

  • 2003 
    The University of Liverpool, PhD Microbiology
  • 1998 
    The University of Edinburgh, BSc. hons Medical Microbiology

Publications

  • 2026
    Exploring Phages Through Play: Creative 3D models for Science Engagement, Access Microbiology https://doi.org/10.1099/acmi.0.001158.v1
  • 2024
    Antimicrobials: An update on new strategies to diversify treatment for bacterial infections, Advances in Microbial Physiology https://doi.org/10.1016/bs.ampbs.2023.12.002
  • 2024
    Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics, J. Vis. Exp. doi:10.3791/64945
  • 2021
    Comparative analysis of gene prediction tools for viral genome annotation , Biorxiv https://doi.org/10.1101/2021.12.11.472104
  • 2021
    Antibiotic resistance profiles and population structure of disease-associated Staphylococcus aureus infecting patients in Fort Portal Regional Referral Hospital, Western Uganda, Microbiology https://doi.org/10.1099/mic.0.001000
  • 2018
    Ram locus is a key regulator to trigger multidrug resistance in Enterobacter aerogenes, Journal of Medical Microbiology doi: 10.1099/jmm.0.000667
  • 2017
    C. jejuni transcriptome changes during loss of culturability in water, PLoSOne doi: 10.1371/journal.pone.0188936
  • 2017
    Evolutionary diversification of P. aeruginosa in an artificial sputum model, BMC Microbiology DOI:10.1186/s12866-016-0916-z
  • 2017
    Fifty important research questions in microbial ecology, FEMS Microbiol Ecol https://doi.org/10.1093/femsec/fix044
  • 2016
    The role of temperate bacteriophages in bacterial infection, FEMS Microbiology Letters doi10.1093/femsle/fnw015
  • 2016
    Temperate phages enhance pathogen fitness in chronic lung infection, ISME J https://doi.org/10.1038/ismej.2016.51
  • 2016
    Temperate phages both mediate and drive adaptive evolution in pathogen biofilms, PNAS https://doi.org/10.1073/pnas.1520056113
  • 2015
    Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections, The ISME Journal. doi: 10.1038/ismej.2014.223
  • 2015
    Polylysogeny magnifies competitiveness of a bacterial pathogen in vivo, Evolutionary Applications DOI: 10.1111/eva.12243
  • 2014
    Recent Advances in Studies of Polymicrobial Interactions in Oral Biofilms, Curr Oral Health Rep https://doi.org/10.1007/s40496-013-0006-3
  • 2014
    Role of environmental survival in transmission of Campylobacter jejuni, FEMS Microbiol. Letts. https://doi.org/10.1111/1574-6968.12488
  • 2012
    Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung, JoVE DOI : 10.3791/3857-v
  • 2012
    Novel therapeutic strategies to counter Pseudomonas aeruginosa infections, Expert Reviews of Anti Infective Therapy DOI: 10.1586/eri.11.168
  • 2012
    Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa , BMC Microbiology https://doi.org/10.1186/1471-2180-12-216
  • 2011
    The effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa, AAC https://doi.org/10.1128/aac.01257-10
  • 2010
    HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms, Pharmacogenetics and Genomics doi: 10.1097/FPC.0b013e328335b02d
  • 2009
    How B-Lactam Antibiotics Enter Bacteria: A Dialogue with the Porins, PLoS One https://doi.org/10.1371/journal.pone.0005453
  • 2008
    Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens, Curr Drug Targets https://doi.org/10.2174/138945008785747824
  • 2008
    The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria, Nat Rev Microbiol. https://doi.org/10.1038/nrmicro1994
  • 2007
    An Early Response to Environmental Stress Involves Regulation of OmpX and OmpF, Two Enterobacterial Outer Membrane Pore Forming Proteins, AAC. DOI:10.1128/AAC.01481-06
  • 2007
    Intrinsic Apoptotic Pathways of Gingival Epithelial Cells Modulated by Porphyromonas gingivalis, Cell Microbiol. https://doi.org/10.1111/j.1462-5822.2007.00931.x
  • 2007
    Short-tailed Stx Phages Exploit the Conserved YaeT Protein to Disseminate Shiga Toxin Genes Amongst Enterobacteria, J Bacteriol. https://doi.org/10.1128/JB.00824-07
  • 2006
    A P. gingivalis Haloacid Dehalogenase Family Phosphatase Interacts with Human Phosphoproteins and is Important for Invasion, PNAS https://doi.org/10.1073/pnas.0509813103
  • 2006
    S. gordonii utilizes several distinct gene functions to recruit P. gingivalis into a mixed community, Mol. Microbiol. doi:10.1111/j.1365-2958.2006.05099.x
  • 2006
    Expression of the Short Fimbriae of Porphyromonas gingivalis is Regulated in Oral Bacterial Consortia , FEMS Microbiol. Lett. https://doi.org/10.1111/j.1574-6968.2006.00357.x
  • 2006
    LuxS Involvement in the Regulation of Genes Coding for Hemin and Iron Acquisition Systems in Porphyromonas gingivalis , Infect. Immun. doi: 10.1128/IAI.01768-05
  • 2005
    Survival of shiga toxin-encoding bacteriophage in a compost model, FEMS Microbiol Letts. DOI:10.1016/j.femsle.2005.03.031
  • 2003
    Immunity profiles of wild-type and recombinant verotoxin-encoding bacteriophages and characterization of novel double lysogens, Infect Immun. doi: 10.1128/IAI.71.6.3409-3418.2003
  • 2001
    Lytic and lysogenic infection of diverse Escherichia coli and Shigella strains by verotoxigenic bacteriophages, Appl Environ Microbiol. doi: 10.1128/AEM.67.9.4335-4337.2001
  • 2001
    Phage mediated transfer of virulence genes, J Chem Tech Biotech. https://doi.org/10.1002/jctb.437

Grants and Contracts

  • 2025
    Relationship Building - Bridging the gap between basic laboratory studies and clinical trials in wound healing biotechnology
    Role:
    PI
    Funding Source:
    IBIC
  • 2024
    Immersive tools for active and creative engagement in STEM subjects
    Role:
    PI
    Funding Source:
    HEIF
  • 2021
    Antimicrobial Surface Coatings for Controlling Infection Transmission
    Role:
    Co-I
    Funding Source:
    HEIF
  • 2020
    Prophage host interactions: pulling back the curtains on Pseudomonas puppet masters
    Role:
    PI
    Funding Source:
    BBSRC BB/T016256/1

Professional Memberships

  • The Microbiology Society
  • Applied Microbiology International

Contact Chloe for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision